These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 25825163
1. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia. Méhes G, Tzankov A, Hebeda K, Anagnostopoulos I, Krenács L, Bedekovics J. Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163 [Abstract] [Full Text] [Related]
2. Image analysis of platelet derived growth factor receptor-beta (PDGFRβ) expression to determine the grade and dynamics of myelofibrosis in bone marrow biopsy samples. Bedekovics J, Szeghalmy S, Beke L, Fazekas A, Méhes G. Cytometry B Clin Cytom; 2014 Sep; 86(5):319-28. PubMed ID: 24810671 [Abstract] [Full Text] [Related]
8. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. Bock O, Höftmann J, Theophile K, Hussein K, Wiese B, Schlué J, Kreipe H. Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123 [Abstract] [Full Text] [Related]
9. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients]. Buhr T, Länger F, Kreft A, Büsche G, Choritz H, Kreipe H. Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296 [Abstract] [Full Text] [Related]
10. Platelet-derived growth factor receptor β activation and regulation in murine myelofibrosis. Kramer F, Dernedde J, Mezheyeuski A, Tauber R, Micke P, Kappert K. Haematologica; 2020 Aug; 105(8):2083-2094. PubMed ID: 31672904 [Abstract] [Full Text] [Related]
11. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl. Thiele J, Kvasnicka HM, Vardiman J. Best Pract Res Clin Haematol; 2006 Aug; 19(3):413-37. PubMed ID: 16781481 [Abstract] [Full Text] [Related]
14. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis]. Gong XB, Zhang XH, Lu XG, Tang QS, Gao X, Yang J. Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188 [Abstract] [Full Text] [Related]
15. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading. Thiele J, Kvasnicka HM. Pathobiology; 2007 Jan; 74(2):89-96. PubMed ID: 17587880 [Abstract] [Full Text] [Related]
16. Peripheral T cell lymphoma, not otherwise specified with myelofibrosis: report of a case with review of the literature. Sekiguchi Y, Shirane S, Shimada A, Ichikawa K, Wakabayashi M, Sugimoto K, Tomita S, Izumi H, Nakamura N, Sawada T, Ohta Y, Komatsu N, Noguchi M. Int J Clin Exp Pathol; 2015 Jan; 8(4):4186-203. PubMed ID: 26097612 [Abstract] [Full Text] [Related]
18. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification. Kvasnicka HM, Thiele J. Pathobiology; 2007 Jan; 74(2):63-71. PubMed ID: 17587877 [Abstract] [Full Text] [Related]
19. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Buhr T, Georgii A, Choritz H. Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741 [Abstract] [Full Text] [Related]